Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients.

Hakeshzadeh F, Tabibi H, Ahmadinejad M, Malakoutian T, Hedayati M.

Ren Fail. 2010;32(9):1109-14. doi: 10.3109/0886022X.2010.510617.

PMID:
20863217
2.

L-carnitine consecutively administered to patients on hemodialysis improves beta-cell response.

Vazelov E, Borissova AM, Kirilov G, Assenova B, Tchetirska M, Krivoshiev S.

Int J Artif Organs. 2003 Apr;26(4):304-7.

PMID:
12757029
3.

Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.

LeSar CJ, Merrick HW, Smith MR.

J Am Coll Surg. 1999 Jul;189(1):73-9; discussion 79-81.

PMID:
10401743
4.

L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.

Perna AF, Acanfora F, Satta E, Lombardi C, Capasso R, Ingrosso D, De Santo NG.

J Nephrol. 2007 Jan-Feb;20(1):63-5.

PMID:
17347975
5.

Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients.

Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F.

Am J Clin Nutr. 1983 Oct;38(4):523-31.

PMID:
6624694
6.

The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.

Bavbek N, Akay H, Uz B, Uz E, Turgut F, Kanbay M, Senes M, Akcay A, Duranay M.

Ren Fail. 2010 Jan;32(2):157-61. doi: 10.3109/08860221003592812.

PMID:
20199175
7.

Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.

Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC.

Clin Nephrol. 2000 Dec;54(6):470-7.

PMID:
11140808
8.

The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.

Kavukçu S, Türkmen M, Salman S, Onvural B, Oktay G, Karaman O, Cevik NT.

Turk J Pediatr. 1998 Jan-Mar;40(1):79-84.

PMID:
9673532
10.

Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation.

Ghisdal L, Broeders N, Wissing KM, Mena JM, Lemy A, Wijns W, Pradier O, Donckier V, Racapé J, Vereerstraeten P, Abramowicz D.

Nephrol Dial Transplant. 2011 Aug;26(8):2700-5. doi: 10.1093/ndt/gfq791. Epub 2011 Feb 1.

PMID:
21285127
11.

Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.

Vaux EC, Taylor DJ, Altmann P, Rajagopalan B, Graham K, Cooper R, Bonomo Y, Styles P.

Nephron Clin Pract. 2004;97(2):c41-8.

PMID:
15218329
12.

Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.

Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K.

Am J Kidney Dis. 1998 Aug;32(2):258-64.

PMID:
9708610
13.

Effect of dialysate composition on the lipid response to L-carnitine supplementation.

Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J.

Kidney Int Suppl. 1989 Nov;27:S259-63.

PMID:
2699997
14.

[Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].

Kudoh Y, Shoji T, Oimatsu H, Kikuchi K, Imura O, Watarai I.

Nihon Jinzo Gakkai Shi. 1984 Feb;26(2):195-202. Japanese. No abstract available.

PMID:
6748336
15.

Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.

Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.

Clin Pharmacol Ther. 2000 Sep;68(3):238-49.

PMID:
11014405
16.

Effects of L-carnitine on arrhythmias during hemodialysis.

Suzuki Y, Narita M, Yamazaki N.

Jpn Heart J. 1982 May;23(3):349-59.

PMID:
6178854
17.

Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.

Guarnieri G, Toigo G, Crapesi L, Situlin R, Del Bianco MA, Corsi M, Lo Greco P, Vasile A.

Contrib Nephrol. 1988;65:1-23. Review. No abstract available.

PMID:
3048873
18.

Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation.

Sloan RS, Kastan B, Rice SI, Sallee CW, Yuenger NJ, Smith B, Ward RA, Brier ME, Golper TA.

Am J Kidney Dis. 1998 Aug;32(2):265-72.

PMID:
9708611
19.

Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial.

Thomas S, Fischer FP, Mettang T, Pauli-Magnus C, Weber J, Kuhlmann U.

Am J Kidney Dis. 1999 Oct;34(4):678-87.

PMID:
10516349
20.

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.

Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A; CHIEF Investigators.

Am J Kidney Dis. 2001 May;37(5):1018-28.

PMID:
11325685

Supplemental Content

Support Center